Cargando…
Ketorolac May Increase Hematoma Risk in Reduction Mammaplasty: A Case-control Study
BACKGROUND: Ketorolac is a potent nonsteroidal anti-inflammatory drug that has valuable analgesic properties but also a hypothetical risk of increased bleeding due to inhibition of platelet activation. The clinical significance of this risk, however, is unclear when it is used after reduction mammap...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908486/ https://www.ncbi.nlm.nih.gov/pubmed/29707458 http://dx.doi.org/10.1097/GOX.0000000000001699 |